New cationic diruthenium complexes of the type [(arene) 2 Ru 2 (SPh) 3 ] + , arene being C 6 H 6 , p-i PrC 6 H 4 Me, C 6 Me 6 , C 6 H 5 R, where R = (CH 2 ) n OC(O)C 6 H 4 -p-O(CH 2 ) 6 CH 3 or (CH 2 ) n OC(O)CH CHC 6 H 4 -p-OCH 3 and n = 2 or 4, are obtained from the reaction of the corresponding precursor [(arene)RuCl 2 ] 2 and thiophenol and isolated as their chloride salts. The complexes have been fully characterised by spectroscopic methods and the solid state structure of [(C 6 H 6 ) 2 Ru 2 (SPh) 3 ] + , crystallised as the hexafluorophosphate salt, has been established by single crystal X-ray diffraction. The complexes are highly cytotoxic against human ovarian cancer cells (cell lines A2780 and A2780cisR), with the IC 50 values being in the submicromolar range. In comparison the analogous trishydroxythiophenolato compounds [(arene) 2 Ru 2 (S-p-C 6 H 4 OH) 3 ]Cl (IC 50 values around 100 mM) are much less cytotoxic. Thus, it would appear that the increased antiproliferative effect of the arene ruthenium complexes is due to the presence of the phenyl or toluyl substituents at the three thiolato bridges.
Keywords: Ruthenium / Arene ligands / Thiolato bridges / CytotoxicityTreatment of an arene-ruthenium dichloride dimer with thiols RSH to lead to cationic trithiolato complexes of the type [(arene) 2 Ru 2 (SR) 3 ] + was shown to proceed through the neutral thiolato complexes [(arene) 2 Ru 2 (SR) 2 Cl 2 ], which have been isolated and characterized for arene = p-MeC 6 H 4 iPr and R = CH 2 Ph (1), CH 2 CH 2 Ph (2), CH 2 C 6 H 4 -p-tBu (3), and C 6 H 11 (4). The single-crystal X-ray structure analysis of the p-tert-butylbenzyl derivative 3 reveals that the two ruthe-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.